You are here

  • Home
  • Archive
  • Volume 91, Issue 1
  • Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIGMS

Article metrics

Article menu

Download PDFPDF

Multiple sclerosis
Original research
Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIGMS

 

Online download statistics by month:

Online download statistics by month: August 2019 to September 2024

AbstractFullPdf
Aug 201918218720
Sep 2019451481140
Oct 201920120083
Nov 201912712634
Dec 201929028656
Jan 202023923275
Feb 202013512931
Mar 202011310827
Apr 2020656127
May 2020666317
Jun 2020504915
Jul 2020938739
Aug 2020676439
Sep 2020888165
Oct 2020575233
Nov 2020656020
Dec 2020656020
Jan 2021484323
Feb 2021444315
Mar 2021757525
Apr 2021272716
May 2021353327
Jun 2021545222
Jul 2021312916
Aug 2021524831
Sep 2021666126
Oct 2021333432
Nov 2021353328
Dec 2021717111
Jan 2022464211
Feb 2022403622
Mar 2022595421
Apr 2022555724
May 2022716923
Jun 2022635615
Jul 2022433723
Aug 2022454315
Sep 2022615662
Oct 2022646053
Nov 2022777138
Dec 2022383634
Jan 2023353341
Feb 2023626025
Mar 2023383033
Apr 20231019831
May 2023454134
Jun 2023272625
Jul 2023293363
Aug 2023403229
Sep 2023635637
Oct 2023444349
Nov 2023535331
Dec 2023565235
Jan 2024221835
Feb 2024343232
Mar 20243534108
Apr 2024433765
May 2024504638
Jun 2024453652
Jul 2024444039
Aug 2024303127
Sep 2024463837
Total452943612220